Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth

about

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth

Item

http://www.wikidata.org/entity/Q56891079

description

scientific article published on 11 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@en

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@nl

type

Item

label

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@en

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@nl

prefLabel

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@en

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@nl

P1476

Inhibition of RON kinase poten ...... d prevent metastatic outgrowth

@en

P2093

Fadi Haroun

http://www.w3.org/2001/XMLSchema#string

Harika Gundlapalli

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Structure and dimerization of a soluble form of B7-1

Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

The blockade of immune checkpoints in cancer immunotherapy

Fiji: an open-source platform for biological-image analysis.

A novel putative receptor protein tyrosine kinase of the met family

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses

P304

e1480286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2018.1480286

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30228950

http://www.w3.org/2001/XMLSchema#string

P921

immunology

immunotherapy

P932

6140584

http://www.w3.org/2001/XMLSchema#string